Asgpr-binding compounds for the degradation of extracellular proteins
US-2024424108-A1 · Dec 26, 2024 · US
US10676509B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10676509-B2 |
| Application number | US-53387609-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 31, 2009 |
| Priority date | Jul 31, 2008 |
| Publication date | Jun 9, 2020 |
| Grant date | Jun 9, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Immobilizable antimicrobial compounds incorporating antimicrobial and/or antifouling components, as can be adhered to various device structures and components.
Opening claim text (preview).
We claim: 1. An antimicrobial compound comprising an ampetoid component, wherein the ampetoid component comprises a trimer of a formula —(—X—Y—Z)— n , wherein X, Y, and Z are independently selected monomeric residues, wherein each monomeric residue is independently selected from proline residues and N-substituted glycine residues, wherein the N-substituents are independently selected from about C 4 - about C 20 linear, branched and cyclic alkyl moieties, α-amino acid side chain moieties and carbon homologs thereof, provided the ampetoid component is amphipathic and has a net positive charge under physiological conditions, an anchor component, wherein the anchor component comprises at least two DOPA residues and a lysine residue, an anti-fouling component, wherein the anti-fouling component comprises at least one N-methoxyethylglycine (N me ) residue, wherein the anti-fouling component couples the ampetoid component and the anchor component, wherein the antimicrobial compound comprises a formula A-(-X—Y—Z—)— n —B—(—N me —) n′ -(-DOPA-Lys-) n″ -DOPA-NH 2 wherein A is selected from H and a terminal N-alkyl substituted glycine residue, N R , wherein R is selected from C 4 -C 20 linear, branched and cyclic alkyl moieties, wherein in the trimer —(—X—Y—Z—)— n , X is selected from an N-(4-(aminobutyl)glycine (N Lys ) residue, at least one of Y and Z is selected from N-(phenylmethyl)glycine (N pm ), (R)—N-(1-phenylethyl)glycine (N gpe ), and (S)—N-(1-phenylethyl)glycine (N spe ) residues, and n is an integer selected from the group consisting of 1-5, wherein B is selected from a covalent bond, an N Lys residue and N Lys -N spe residues, wherein n′ is an integer selected from the group consisting of 10-25, and wherein n″ is an integer selected from the group consisting of 1-5. 2. The compound of claim 1 wherein A is H; and n is 3-4. 3. The compound of claim 2 wherein n is 3; and B is N Lys -N spe residues, said ampetoid component of a formula H—(—N Lys -N spe —N spe —)—N Lys -N spe . 4. The compound of claim 2 wherein n is 4; and B is selected from a covalent bond and an N Lys residue, said ampetoid component of a formula H—(—N Lys —N spe —N spe ) 4 or H—(—N Lys —N spe —N spe —)— 4 N Lys . 5. The compound of claim 1 wherein said ampetoid component is of a formula H—(—N Lys —N spe —N spe —N Lys —N spe -L-Pro-(-N Lys —N spe —N spe ) 2 . 6. The compound of claim 2 wherein A is a terminal N-alkyl substituted glycine residue, said alkyl substituent R selected from about C 6 to about C 18 linear alkyl moieties; B is a covalent bond; and n is selected from 1 and 2. 7. The compound of claim 2 wherein A is a terminal N-alkyl substituted glycine residue, said alkyl substituent R selected from about C 6 to about C 18 linear, branched and cyclic alkyl moieties; B is an N Lys residue; and n is 1. 8. The compound of claim 7 wherein said ampetoid component is of a formula H—N tridec —N Lys —N spe —N spe —N Lys . 9. An article of manufacture comprising a metal substrate and a coating coupled thereto, said coating comprising an antimicrobial compound selected from compounds of claim 1 . 10. The article of claim 9 wherein said anchor component comprises a (DOPA-Lys) 2 -DOPA sequence of residues. 11. The article of claim 9 wherein said substrate is a medical device. 12. The article of claim 11 wherein said substrate comprises titanium oxide. 13. An antimicrobial compound of a formula H—N Lys —N spe —N spe —N Lys —N spe -L-Pro-(N Lys —N spe —N spe ) 2 —(N me ) 20 -(DOPA- Lys ) 2 -DOPA- NH 2 .
by chemical synthesis · CPC title
Macromolecular compounds · CPC title
having 5 to 11 amino acids · CPC title
by giving articles subject to fouling a special shape or arrangement · CPC title
Paints containing biocides, e.g. fungicides, insecticides or pesticides (C09D5/16 takes precedence) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.